Search results for: 'Programmable Communications Outlook and Opportunities '
- Did you mean
- programmable communications outlook ad opportunities
- Related search terms
- Outlook 2023: Top 10 Predictions for the Global Commercial Vehicles Market
- Outlook 2023: Top 5 Predictions for the Global Bus and Coach Industry Market
- AND 6153=5227-- cSlQ
- programmable power supply market global 2024 2030
- programmable power supply market global 2024 2024
-
22 May 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Advanced RNA Therapies, Cancer Vaccines, Immunotherapies, and Precision Medicine
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping therapeutics, diagnostics, and drug delivery across infectious diseases, oncology, rare genetic disorders, autoimmune conditions, cardiovascular disease, pulmonary fibrosis, neurodegeneratio...
$950.00 -
16 Sep 2019  |  North America  |  Market Research
Digital Twins Outlook in Healthcare, 2019—2025
Opportunities for Growth in Healthcare Digital Analytics
Digital Twin technology, or the application of predictive analytics to fields as diverse as manufacturing and space science, is now being considered in the context of healthcare. The attraction is obvious: if one can develop a computer model of a patient, perhaps one can test treatments on the model before applying them to the individual. Rather t...
$1,500.00
Special Price $1,125.00 save 25 %
-
25 Sep 2017  |  Europe  |  Market Research
Growth Opportunity Assessment of Healthcare IT Market in France, Forecast to 2021
eHealth Strategy 2020 and Digital Hospital Programme to Elevate Maturity of HCIT in France
UK, Germany, France and Spain collectively spend more than $6 billion on healthcare information technology (healthcare IT) while regional adoption stands at almost 80%. Healthcare IT markets in these countries are ready to embark upon the next level of digitalisation where providers move from data capturing solutions to those that can derive value ...
$3,000.00
Special Price $2,250.00 save 25 %
-
03 Jan 2018  |  North America  |  Market Outlook
Global Healthcare Industry Outlook, 2018
Value-based Care Will Continue to Drive Growth Opportunities for Emerging Technologies as They Move Out form Pilot Testing into Production Environments
In this research deliverable, Frost & Sullivan provides bold perspectives and predictions for the global healthcare industry in 2018. The markets covered include pharmaceuticals and biotech, in-vitro diagnostics, medical technologies, medical imaging, and healthcare IT. The analysis captures sectoral and regional trends and provides predictions for...
$4,950.00
Special Price $3,712.50 save 25 %
-
12 Aug 2014  |  Asia Pacific  |  Market Research
Malaysia Healthcare Outlook
Showcasing Value Propositions for Investors
The Malaysia healthcare outlook addresses the investment opportunities across various segments. The study explores the developments in the hospital industry, IVD and POCT industry, pharmaceutical industry, biotechnology industry, medical devices industry, connected health industry, and the aged care industry in the country. The study explores oppor...
$3,950.00
Special Price $2,962.50 save 25 %
-
20 Mar 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in Cell-based Liver Therapy, Bacteriophage Therapeutics, Cell & Gene Therapy, and Small Molecule Therapeutics
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations transforming respiratory medicine, liver regeneration, metabolic disease management, infectious disease therapeutics, neurological disorders, cardiovascular risk reduction, oncology workflows, and nex...
$950.00 -
30 Apr 2007  |  North America  |  Market Research
U.S. Generic Pharmaceuticals Outlook
This research service provides an outlook of the U.S. generic pharmaceuticals market and includes the unbranded generic drugs sold within the U.S. The research service provides a market overview, trends, competitive landscape, market forecasts, market share analysis, industry challenges and opportunities.
$4,950.00
Special Price $3,712.50 save 25 %
-
06 Jan 2016  |  Global  |  Market Outlook
Global Healthcare Industry Outlook, 2016
Next-Gen Wearables, Clinical Retail and POC Tests Drive Opportunity through Value-Based Transformation
In this research deliverable, Frost & Sullivan’s senior analyst team across the healthcare sector provides bold perspectives and predictions for the industry in 2016. The markets covered include pharmaceuticals and biotech, medical devices, medical imaging, and healthcare IT, amongst others. The analysis captures the impact of trends that are expec...
$4,950.00
Special Price $3,712.50 save 25 %
-
17 Apr 2023  |  Asia Pacific  |  Market Outlook
Asia-Pacific Medical Imaging Equipment and Informatics Outlook, 2023
Focus on Domestic Manufacturing, Mobile Imaging, and Accessibility Solutions Create New Growth Opportunities
The Asia-Pacific medical imaging and informatics market revenue is forecast to increase by 11.4% in 2023, mainly driven by the high procurement of medical imaging equipment and radiology IT solutions in the informatics sector. Large hospitals widely adopt digital radiography and ultrasound systems as the devices are operator-dependent and need a sk...
$4,950.00
Special Price $3,712.50 save 25 %
-
21 Aug 2026  |  Global  |  Technology Research
Innovations and Growth Opportunities in AI-Driven Biomanufacturing, Advanced Cell and Gene Therapies, and Precision Immunotherapy
Life Science, Health & Wellness Technology Opportunity Engine
This edition of the Life Science, Health & Wellness Technology Opportunity Engine (TOE) provides a comprehensive overview of breakthrough innovations reshaping biomanufacturing, cell and gene therapy, precision immunotherapy, anti-infectives, and neurotherapeutics across oncology, infectious disease, nephrology, and neurodegenerative disease. It hi...
$950.00